Pfizer Inc. (NYSE:PFE) is exiting ViiV Healthcare, a joint venture with GSK and Shionogi. Shionogi will pay $2.13 billion for more shares, increasing its stake to 21.7%. Pfizer will receive $1.88 billion for its 11.7% holding. The deal is set to close in Q1 of 2026. Pfizer is preparing for a consumer-driven obesity drug market. CEO Albert Bourla sees potential growth similar to Viagra’s launch in 1998. Pfizer spun off its Viagra business in 2020. Pfizer is a global biopharmaceutical company focused on research and commercializing medicines worldwide.

Read more at Yahoo Finance: Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership